Joint venture between GSK and Verily developing bioelectronic medicines that modulate peripheral nerves for chronic disease treatment.
Develops minimally-invasive implanted muscle-machine (neuromuscular) interfaces for prosthetic and robotic control.
Join to open the full comparison.
The Briefing, free for life.